A phase II study of the combination of gemcitabine plus carboplatin as the neoadjuvant treatment in locally advanced breast cancer
Objective: Although anthracycline-based regimen is standard neoadjuvant chemotherapy (NAC) for locally advanced breast cancer (LABC), there is some concern over its toxicities such as alopecia and cardiotoxicity. Gemcitabine is another active agent in metastatic breast cancer after failure to anthra...
Saved in:
Main Authors: | Suthinee Ithimakin, Adune Ratanawichitrasin, Vutisiri Veerasarn, Charuwan Akewanlop, Nopadol Soparattanapaisarn, Supakorn Rojananin, Pornchai O-charoenrat, Poramaporn Prasarttong-osoth, Vichien Srimuninnimit |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/32500 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Primary hyperparathyroidism: 11-year experience in a Single Institute in Thailand
by: Poramaporn Prasarttong-Osoth, et al.
Published: (2018) -
Comparison Between Gemcitabine-Carboplatin and Combination of Gemcitabine-Carboplatin and Celecoxib in Urothelial Carcinoma Cell Apoptosis
by: Widya Sakti Pratama, et al.
Published: (2019) -
The Differences of Apoptosis Effects Between Combination of Meloxicam with Gemcitabine-Carboplatin Chemotherapy Compared to Gemcitabine-Carboplatin Chemotherapy Alone in Urothelial Carcinoma Culture Cells
by: Ananta Cahyo Nugroho, et al.
Published: (2019) -
Breast cancer subtypes identified by the ER, PR and HER-2 status in thai women
by: Suebwong Chuthapisith, et al.
Published: (2018) -
PERBEDAAN EFEK APOPTOSIS PEMBERIAN KOMBINASI MELOKSIKAM DAN KEMOTERAPI GEMCITABINE CARBOPLATIN DIBANDINGKAN KEMOTERAPI GEMCITABINE CARBOPLATIN PADA SEL KULTUR KARSINOMA UROTHELIAL
by: Ananta Cahyo Nugroho, NIM01131896305
Published: (2018)